![Sandra Aung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sandra Aung
Direttore Tecnico/Scientifico/R&S presso AMBRX INC
Profilo
Sandra Aung is currently the Chief Clinical Development Officer & Senior VP at OncoSec Medical, Inc. and the Chief Clinical Officer at Ambrx, Inc. She holds a doctorate degree from Vanderbilt University.
Posizioni attive di Sandra Aung
Società | Posizione | Inizio |
---|---|---|
ONCOSEC MEDICAL INCORPORATED | Corporate Officer/Principal | 12/10/2020 |
AMBRX INC | Direttore Tecnico/Scientifico/R&S | 01/02/2023 |
Formazione di Sandra Aung
Vanderbilt University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
Aziende private | 1 |
---|---|
Ambrx, Inc.
![]() Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Sandra Aung